The market for dental membrane and bone graft substitutes is expected to reach US$ 1.1 billion by 2027

The prevalence of oral problems has increased across all age groups, resulting in an increase in global demand for dental surgeries. As a result, newer and better materials for use as dental membrane and bone graft substitutes have been discovered. Human cell sources and other species have traditionally been the most popular bone graft substitutes. Despite the growing popularity of other materials, these segments are expected to remain the most important in the global dental membrane and bone graft substitutes market from 2019 to 2027.

However, collagen, a structural protein found in human bones, is increasingly being used as a biocompatible dental membrane and bone graft substitute, causing its popularity to skyrocket in recent years because it promotes wound healing and improves clinical outcomes. As a result, the collagen segment was valued at US$ 40 million in 2018, with a relatively small share of one-fifth of the global dental membrane and bone graft substitutes market but is expected to grow the fastest at an 8.5 percent CAGR during the forecast period.

In 2018, dental membranes, which prevent gums from growing into the bone cavity, accounted for 40% of the total market share of dental membrane and bone graft substitutes by product type. Resorbable dental membranes accounted for 90% of this in 2018, equivalent to US$ 213 Mn, and its share is expected to double by the end of 2027.

This popularity can be attributed to the numerous advantages they provide, such as cost-effectiveness, a reduction in patient morbidity, and the elimination of the need for membrane removal, which shortens the healing process. This is especially important given the increased demand for collagen resorbable dental membranes that promote oral tissue regeneration. Even as the global incidence of dental problems rises and the demand for procedures rises, the costs associated with these advanced procedures and treatments rise as well. These rising costs can be attributed to the rising costs of materials used, such as implants, membrane, and graft materials and substitutes, and customization, which is provided as a standard for all patients.

The length of dental treatments, which often determines the cost of the procedure, also contributes to this. These factors have had a restraining effect on the global dental membrane and bone graft substitutes market and are expected to continue doing so throughout the forecast period, preventing the market from growing to its full potential.

The global market for dental membrane and bone graft substitutes is moderately consolidated, with the top five companies accounting for 55% of the market share. Geistlich Pharma AG, Institut Straumann AG, Dentsply Sirona, Danaher Corporation and Zimmer Biomet are among the companies that have recently focused on expanding their product offerings to include bio-based materials for implantable devices. For example, Zimmer Biomet announced the launch of OsseoGuard non-resorbable dental membranes and sutures in February 2019, adding to its already extensive product portfolio.

To strengthen their product portfolios, these players are focusing on organic and inorganic growth strategies. In order to compete in the global dental membrane and bone graft substitutes market, they have implemented strategies such as collaborations and acquisitions, geographic expansion, and investment in research and development.